PathoNostics offers multiplex real-time PCR assays for the diagnosis of superficial and invasive fungal infections as well as the identification of multi-azole resistance. Our assays advance the diagnosis of fungal infections and allow antifungal therapy to be more appropriately targeted. Currently 3 products are available: AsperGenius®, DermaGenius®, and PneumoGenius®.

PathoNostics

“Evaluation of the AsperGenius on plasma samples” published in JCM

Friday, June 02, 2017 – The manuscript entitled `An analytical and clinical evaluation of the PathoNostics AsperGenius® Assay for the detection of invasive aspergillosis and resistance to azole antifungal drugs direct from plasma samples.´ is now published in JCM.